Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorderActive, not recruitingPhase 22026-10-01NCT04464980

7 results · Page 1 of 1

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Adapt Integrated Health CareRoseburgUnited States1
Adapt Integrated Health CareWinstonUnited States1
Aspire Health PartnersOrlandoUnited States1
Bellevue Hospital CenterNew YorkUnited States6
Center for Psychiatric and Chemical Dependency Services (CPCDS)PittsburghUnited States1
Chestnut Ridge CenterMorgantownUnited States1
Dartmouth Hitchcock - ATPLebanonUnited States1
Gateway Community ServicesJacksonvilleUnited States3
Gibson Center for Behavioral ChangeCape GirardeauUnited States1
Huntsman Mental Health Institute / University of UtahSalt Lake CityUnited States1
Internal Medicine Recovery Engagement Program (IM-REP)PittsburghUnited States1
Liberation Programs, Inc.BridgeportUnited States1
McLean HospitalBelmontUnited States47
Mountain Manor / Maryland Treatment CentersBaltimoreUnited States1
Operation PARClearwaterUnited States1
Shoreline Behavioral Health ServicesConwayUnited States2
Square Medical Group, LLCNewtonUnited States1
Stanley Street Treatment and Resources, Inc.Fall RiverUnited States1
Tarzana Treatment Centers, Inc.TarzanaUnited States1
University of Arkansas for Medical Sciences (UAMS) / Center for Addiction Services and Treatment (CAST)Little RockUnited States1
University of New Mexico Addiction and Substance Abuse ProgramAlbuquerqueUnited States1